← Browse by Condition
Medical Condition

obsessive compulsive disorder

Total Trials
18
Recruiting Now
18
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for obsessive compulsive disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — obsessive compulsive disorder Clinical Trials

How many clinical trials are currently recruiting for obsessive compulsive disorder?
ClinicalMetric currently tracks 18 actively recruiting clinical trials for obsessive compulsive disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 18. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for obsessive compulsive disorder?
obsessive compulsive disorder research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a obsessive compulsive disorder clinical trial?
Eligibility criteria for obsessive compulsive disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Severance Hospital 1 trial
Johns Hopkins University 1 trial
Istanbul University - Cerrahpasa 1 trial
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 1 trial
Vanderbilt University Medical Center 1 trial

Recruiting Clinical Trials

NCT02431845
Recruiting

Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder

Enrollment
200 pts
Location
South Korea
Sponsor
Severance Hospital
View Trial →
NCT06407648
Recruiting

Using Personalized Assessments in the Treatment of Childhood OCD

Enrollment
30 pts
Location
United States
Sponsor
Johns Hopkins University
View Trial →
NCT07561528
Recruiting

Electrophysiological Biomarkers and Treatment Response to Accelerated Transcranial Magnetic Stimulation in Patients With Obsessive-Compulsive Disorder

Enrollment
30 pts
Location
Turkey (Türkiye)
Sponsor
Istanbul University - Cerrahpa...
View Trial →
NCT06724029
Recruiting

Neurosurgical Outcome Network

Enrollment
4,500 pts
Location
Italy
Sponsor
Fondazione I.R.C.C.S. Istituto...
View Trial →
NCT00575081
Recruiting

Physiological Brain Atlas Development

Enrollment
5,000 pts
Location
United States
Sponsor
Vanderbilt University Medical ...
View Trial →
NCT06346301
Recruiting

Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.

Enrollment
36 pts
Location
Netherlands
Sponsor
Academisch Medisch Centrum - U...
View Trial →
NCT05048251
Recruiting

Individually Targeted Neuromodulation for Contamination-based OCD

Enrollment
50 pts
Location
United States
Sponsor
Mclean Hospital
View Trial →
NCT07065669
Recruiting

Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation

Enrollment
30 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT02844049
Recruiting

European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS

Enrollment
60 pts
Location
France, Germany, Swe...
Sponsor
University Hospital, Grenoble
View Trial →
NCT07146438
Recruiting

Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder

Enrollment
48 pts
Location
United States
Sponsor
Adam Frank
View Trial →
NCT06628752
Recruiting

Deep Brain Stimulation for Obsessive-compulsive Disorder

Enrollment
26 pts
Location
Sweden
Sponsor
Umeå University
View Trial →
NCT06494735
Recruiting

Effect of the French Version If the Metagognitive Bibliotherapy Program "MYMCT" on Obsessive-compulsive Symptoms

Enrollment
114 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT07031544
Recruiting

Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder

Enrollment
60 pts
Location
China
Sponsor
Shanghai Mental Health Center
View Trial →
NCT03953014
Recruiting

Pharmacogenetics of Antidepressant-Induced Disinhibition

Enrollment
120 pts
Location
Canada
Sponsor
University of Calgary
View Trial →
NCT07622654
Recruiting

Effect of Emotion-Focused Acceptance and Commitment Therapy on Obsessive-Compulsive Disorder Symptom Severity

Enrollment
36 pts
Location
Turkey (Türkiye)
Sponsor
Mehmet Emrah Karadere
View Trial →
NCT04723485
Recruiting

Evaluation Study: Obsessive-compulsive Disorders in Childhood and Young Adulthood

Enrollment
625 pts
Location
Switzerland
Sponsor
Susanne Walitza
View Trial →
NCT05609916
Recruiting

CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD

Enrollment
200 pts
Location
United States
Sponsor
Baylor College of Medicine
View Trial →
NCT06542224
Recruiting

Identifying Local Field Potential Biomarkers for Obsessive-compulsive Disorder Treatment With Deep Brain Stimulation

Enrollment
16 pts
Location
China
Sponsor
West China Hospital
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology